Journal of Venomous Animals and Toxins including Tropical Diseases
Scope & Guideline
Fostering Insights into Venomous Animals and Their Threats
Introduction
Aims and Scopes
- Venomics and Proteomics:
The journal extensively covers studies on the composition and functional analysis of venoms from a variety of species, including snakes, spiders, and other venomous animals. This research often employs advanced techniques such as proteomics to characterize venom components and explore their biological activities. - Toxinology and Therapeutic Applications:
A significant focus is placed on the therapeutic potential of venom components, including their use in drug development and disease treatment. This includes research on analgesic properties, anti-cancer effects, and other pharmacological applications of toxins. - Ecological and Evolutionary Studies:
The journal also addresses ecological and evolutionary aspects of venomous species, such as their interactions within ecosystems and adaptations over time. This includes studies on the evolutionary significance of venoms and their roles in predator-prey dynamics. - Clinical and Public Health Implications:
Research addressing the clinical implications of venomous bites and stings, including envenomation treatment strategies and the development of antivenoms, is a critical area of focus. This encompasses studies on the pathophysiology of envenomation and the socio-economic impacts of venomous species. - Innovative Methodologies:
The journal promotes innovative research methodologies in toxinology, including in vitro and in vivo experimental approaches, molecular techniques, and biostatistical analyses, contributing to robust scientific inquiry in the field.
Trending and Emerging
- Bioprospecting for Anti-Cancer Compounds:
There is an increasing interest in exploring snake venoms and other toxins for their potential anti-cancer properties. This trend reflects a broader shift towards utilizing natural products in cancer therapeutics, highlighting the importance of venoms as a source of bioactive molecules. - Immunomodulatory Effects of Venoms:
Emerging research is focusing on the immunomodulatory effects of various venoms, particularly in relation to autoimmune diseases and other inflammatory conditions. This theme underscores the potential of venom components in modulating immune responses and developing new treatments. - Neuroprotective and Neurotoxic Studies:
Research is increasingly addressing the dual roles of venoms in neuroprotection and neurotoxicity. Studies are exploring how specific venom components can protect neuronal cells from damage, suggesting a promising avenue for treating neurodegenerative diseases. - Advancements in Antivenom Development:
There is a growing emphasis on innovative approaches to antivenom development, including the exploration of new types of antivenoms and alternative therapies for snakebite victims. This reflects an urgent need to improve treatment outcomes in regions affected by snakebites. - Integration of Omics Technologies:
The use of omics technologies (genomics, proteomics, metabolomics) in toxinology is on the rise, allowing for comprehensive analyses of venom composition and function. This trend indicates a movement towards more integrative and systems-level approaches in understanding venomous species.
Declining or Waning
- Historical Perspectives on Venomous Species:
Research focusing on the historical context and evolutionary lineage of venomous species, while still relevant, seems to be less frequently published. This trend may indicate a shift towards more immediate applications and experimental studies rather than historical analysis. - General Studies on Venom Composition without Application Focus:
There appears to be a decrease in studies that solely describe venom composition without linking it to specific therapeutic applications or biological functions. This shift may be due to a growing expectation for research to demonstrate practical implications. - Non-Therapeutic Environmental Studies:
While environmental studies related to venomous animals are still published, there is a noticeable decline in research that does not directly tie back to health implications or therapeutic potential, suggesting a narrowing of focus towards more practical applications.
Similar Journals
EXCLI Journal
Pioneering Research for Global Impact in ZoologyEXCLI Journal is an esteemed open access scientific publication dedicated to the fields of Animal Science and Zoology, Drug Discovery, Molecular Medicine, and Pharmacology. Established in 2002 and published by the EXCLI JOURNAL MANAGING OFFICE, this journal has quickly ascended in the academic community, securing a Q1 classification in significant categories like Animal Science and Drug Discovery in the 2023 rankings. With an impressive Scopus Rank of #13 out of 490 in its primary field, the journal maintains high standards for quality research and innovation. The EXCLI Journal is committed to disseminating progressive findings with global relevance, providing a platform for researchers, professionals, and students to engage with cutting-edge studies. With a compelling aim to foster knowledge exchange and collaboration among scientists worldwide, this journal signifies a critical resource for those invested in advancing our understanding of animal science and pharmaceutical research.
Journal of Pharmacological Sciences
Empowering health through cutting-edge pharmacological insights.Journal of Pharmacological Sciences is a leading peer-reviewed academic journal dedicated to the field of pharmacology, published by the Japanese Pharmacological Society. Since its inception, this journal has offered an essential platform for the dissemination of high-quality research, contributing significantly to advancements in molecular medicine and pharmacology. With an impact factor that places it in the prestigious Q2 quartile for both categories, the journal has established itself as a credible source of innovative findings and methodologies since its transition to Open Access in 2015. This accessibility enables a broader audience, including researchers, healthcare professionals, and students, to engage with valuable insights and discussions pertinent to drug development, pharmacodynamics, and therapeutic strategies. Based in Kyoto, Japan, the journal serves as a vital resource for the global pharmacological community, encouraging collaboration and research that leads to improved health outcomes. For more information, submissions, and access to the latest research, visit the journal’s website.
PTERIDINES
Unlocking the Secrets of Pteridines in Health and DiseasePTERIDINES is a unique journal dedicated to the study of pteridines and their implications in biochemistry and clinical research. Published by DE GRUYTER POLAND SP Z O O, this Open Access journal has been a vital resource since its inception in 1989, steadily evolving to include a diverse range of topics pertinent to molecular medicine and biochemistry. With its current classification in the Q4 quartile for Biochemistry, Clinical Biochemistry, and Molecular Medicine, PTERIDINES offers a platform for researchers and professionals seeking to disseminate and access groundbreaking findings. Although the journal has a modest Scopus ranking, it serves as an important outlet for both emerging and established scholars in the field, particularly those focusing on the biochemical roles of pteridines. Based in Germany, the journal invites contributions from around the globe, providing equitable access to all readers since 2018, making significant strides towards inclusive scientific discourse. As such, PTERIDINES is a valuable asset for anyone engaged in the exploration of pteridines and their multifaceted roles in health and disease.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
Pioneering Discoveries in Pharmacology and PhysiologyCLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, published by WILEY, is a premier journal that serves as a vital resource for researchers, professionals, and students in the fields of pharmacology and physiology. With ISSN 0305-1870 and E-ISSN 1440-1681, this journal has established itself as a significant contributor to scientific dialogue since its inception in 1974. Currently spanning until 2024, it consistently publishes cutting-edge research addressing both experimental and clinical advancements in pharmacology and physiology. Recognized for its quality, it holds a Q2 ranking in the 2023 Pharmacology category and notable Q3 rankings in both Physiology and Medical Physiology. The journal's coverage of topical issues not only ensures a robust platform for innovative findings but also fosters collaborations across disciplines. Although not an Open Access journal, its curated content is invaluable for advancing knowledge, as evidenced by its solid Scopus rankings, which place it within the top percentiles of its field. Engaging with this journal means staying at the forefront of research that shapes clinical practices and experimental methodologies.
CURRENT MEDICINAL CHEMISTRY
Catalyzing Breakthroughs in Health Sciences.Current Medicinal Chemistry is a leading journal published by Bentham Science Publishers Ltd, known for its rigorous focus on the multifaceted realm of medicinal chemistry. With an ISSN of 0929-8673 and E-ISSN 1875-533X, the journal plays a crucial role in disseminating high-quality research findings that bridge the gap between chemistry and health sciences. Operating from Sharjah, United Arab Emirates, it has been a prominent scholarly resource since its inception in 1994, and is expected to continue until 2024. Current Medicinal Chemistry has earned its place in the academic community with an impressive impact factor and categorization in Q1 and Q2 quartiles across various disciplines, including Organic Chemistry, Biochemistry, Drug Discovery, and Pharmacology, highlighting its substantial contribution to these fields. Notably, it ranks 24th in Organic Chemistry and is within the 88th percentile, underscoring its appeal to researchers, professionals, and students alike who are keen on exploring cutting-edge advancements in drug design and development. Although it is not an open-access journal, it provides vital content that informs and inspires innovation in medicinal chemistry, appealing to a global audience committed to enhancing human health through scientific discovery.
Journal of Pharmaceutical and Biomedical Analysis
Elevating standards in pharmaceutical and biomedical analysis.The Journal of Pharmaceutical and Biomedical Analysis, published by ELSEVIER and available in print and online formats, stands as a pivotal source of knowledge in the realms of Analytical Chemistry, Clinical Biochemistry, Drug Discovery, and Pharmaceutical Science. With an ISSN of 0731-7085 and an e-ISSN of 1873-264X, this journal is dedicated to publishing high-quality research that advances the understanding and development of analytical techniques in pharmaceuticals and biomedicine. The journal has earned a solid reputation, reflected in its Q2 category rankings across five distinct fields for 2023, and boasts impressive Scopus rankings, signaling its robust impact within the academic community. The Journal of Pharmaceutical and Biomedical Analysis serves as an essential resource for researchers, professionals, and students alike, providing actionable insights and fostering innovation that can directly influence future advancements in drug development and biomedical applications.
Recent Patents on Anti-Cancer Drug Discovery
Transforming Discoveries into Therapeutic SolutionsRecent Patents on Anti-Cancer Drug Discovery, published by Bentham Science Publishers Ltd, is an esteemed peer-reviewed journal specializing in the innovative intersection of pharmaceutical science and oncology. With an ISSN of 1574-8928 and an E-ISSN of 2212-3970, this journal aims to provide a comprehensive platform for the dissemination of recent developments in anti-cancer drug discovery, addressing critical issues and breakthroughs that influence cancer research and treatment. The journal spans from 2006 to 2024 and is indexed in several prestigious databases, showcasing its relevance with a Q3 ranking in key categories such as Cancer Research and Drug Discovery as of 2023. Its status of being open access reflects a commitment to making valuable scientific findings widely available, promoting collaboration and advancement in the field. With a dedicated focus on advancing knowledge in cancer therapeutics, the journal serves as a vital resource for researchers, healthcare professionals, and students aiming to contribute to the fight against cancer.
Bulletin of Russian State Medical University
Advancing Medical Knowledge in the Heart of RussiaBulletin of Russian State Medical University, published by the esteemed PIROGOV RUSSIAN NATL RESEARCH MEDICAL UNIV, serves as a crucial platform for advancing the field of medicine, particularly in the context of Russian healthcare advancements. With an ISSN of 2500-1094 and an E-ISSN of 2542-1204, this journal has emerged as a valuable resource for researchers, professionals, and students alike, enriching the academic landscape since its inception. Although categorized in the Q4 quartile for Medicine (miscellaneous) and currently ranked #385 out of 636 in the Scopus database, its ongoing commitment to disseminating vital research and clinical studies positions it as a respected, though evolving, contributor to the global medical community. Operating without an open-access model, it ensures the dissemination of quality-controlled scientific information while maintaining professional integrity. Spanning the intersecting domains of healthcare practices and medical science, the journal strives to provide insights and promote discussions that address contemporary challenges in the field, making it an essential read for anyone looking to stay at the forefront of medical research and practices in Russia and beyond.
Toxicon-X
Innovating Insights into Toxicology and Public HealthToxicon-X is a prestigious journal published by ELSEVIER, specializing in the dynamic field of toxicology. With an impact factor indicative of its excellence and rigor—ranked Q1 in Toxicology as of 2023, and positioned at #40 out of 133 in Scopus's Pharmacology, Toxicology, and Pharmaceutics category—this journal is a vital resource for researchers, practitioners, and students alike. Since its inception in 2019, Toxicon-X has embraced an Open Access model, enhancing accessibility and transparency of research findings. This ensures that crucial studies on toxic agents and their effects reach a broader audience, driving advancements in public health and safety. The journal is based in the United Kingdom and caters to a diverse international readership, with its scope encompassing novel research, reviews, and insights into emerging toxicological challenges. As we move towards the 2024 convergence year, Toxicon-X remains committed to fostering a deeper understanding of toxic substances, their mechanisms, and implications for human and environmental health.
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
Advancing Knowledge in Tropical MedicineREVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO is a prestigious open-access journal that has been publishing significant research in the field of tropical medicine since its inception in 1961. Produced by the Instituto de Medicina Tropical de São Paulo, the journal boasts a commendable Q3 ranking in both the categories of Infectious Diseases and Medicine (miscellaneous), as per the latest 2023 metrics. With an ISSN of 0036-4665 and E-ISSN of 1678-9946, it serves as a prominent platform for scholars and professionals to disseminate their findings and insights on pressing health issues prevalent in tropical regions, particularly those relevant to Brazil and beyond. This journal is essential for researchers and practitioners who seek to advance their understanding and apply innovative solutions in tropical medicine, thus addressing the distinct challenges posed by infectious diseases in diverse populations. The journal is accessible through various open access platforms, ensuring that critical research is available to a global audience, fostering knowledge sharing and collaboration.